Kite Pharma is working on a treatment which involves taking a cancer patient's own t-cells out of their body, genetically modifying them to better target cancer, and then re-administering them. Its CEO Arie Belldegrun, provides insight to the positive study with the therapy.» Read More
California's mountains have risen more than half an inch, thanks to the absence of water to weigh them down, a study found. NBC News reports.
CNBC's Andrew Ross Sorkin looks back on some of the best ice bucket challenge videos from last week, including from Bill Gates, saying the campaign has now hit China.
NEW YORK— After more than a year of public criticism of its treatment of killer whales, SeaWorld said Friday that it will build new, larger environments at its theme parks and will fund additional research on the animals along with programs to protect ocean health and whales in the wild.
Lance Slaughter from the ALS Association, discusses the phenomenon spreading across social media to dump a bucket of ice over your head to raise awareness for ALS.
CNBC's Meg Tirrell explains what ALS, or Lou Gehrig's disease is, and what is known about treating the disease.
CNBC looks at which countries may be worst hit, both environmentally and economically, by climate change.
Is the world ready for genetically modified babies? Here's how close we really are, explains Jessica Cussins of the Center for Genetics and Society.
CNBC's Meg Tirrell reports the World Health Organization has convened a panel of medical ethicists to discuss the potential treatment for Ebola patients with experimental therapies.
With the World Health Organization declaring Ebola an international public health emergency, CNBC's Meg Tirrell discusses the use of experimental drugs as a last resort to treat patients stricken with Ebola, cancer and other disease.
The World Health Organization has declared the Ebola virus an international public health emergency. CNBC's Meg Tirrell reports the details.
The FDA has ruled to allow the potential use of drug maker Tekmira's Ebola drug on patients, reports CNBC's Meg Tirrell.
Irwin Redlener author of "Americans at Risk," weighs in on the Ebola outbreak and discusses if the U.S. is adequately prepared to handle an epidemic.
President Obama discusses the Ebola outbreak, and the unproven and untested drug in the U.S. that appears to be helping infected American patients.
Tom Geisbert, University of Texas Medical Branch, shares concerns for experimental treatments for the Ebola virus.
Darria Long Gillespie, Emory University Hospital emergency physician, discusses at what point companies will begin to invest in vaccines to treat rare diseases like Ebola.
CNBC's Eamon Javers reports two American aid workers infected with Ebola are being treated at Emory Hospital in Atlanta today and the U.S. Centers for Disease Control and Prevention is sending 50 additional experts to Africa.
Breaking down the realistic threat of Ebola, and whether hospitals are prepared, with Dr. Peter Hotez, M.D. of Baylor College of Medicine.
Compassionate use is a way for companies to provide experimental drugs outside of clinical trials for patients with no other options. CNBC's Meg Tirrell reports on the risks for patients and drug makers.
Xenex Disinfection Services hopes to fight the war against Ebola. Its CEO Morris Miller shares a demonstration of the company's disinfection robot Sara, which he claims can destroy a deadly virus in 5-10 minutes.
The second American with Ebola has arrived in Atlanta, reports CNBC's Sue Herera.